Introduction
The Nrf2 (nuclear factor erythroid 2-related factor 2) transcription factor plays ak ey role in cellulars tress response mechanisms, controlling the transcription of more than 1000 genes involved in detoxification, anti-oxidant, metabolic and anti-inflammatory activities. [1] [2] [3] Under unstressed conditions, Nrf2 is retained in the cytoplasm in as ilent form by its repressor protein, Keap-1 (Kelch-like ECH-associated protein 1), which contains as ubset of 27 highlyr eactive cysteine (Cys) residues in Human. Oxidative and environmental stimuli modify the cysteine residues of Keap-1, thus enabling translocation of Nrf2 to the nucleus where it binds to the antioxidant responsive element (ARE) located in the promoter region of detoxifying and protectiveg enes. Keap-1 also controlsN rf2 by mediating its ubiquitination. Among Nrf2 dependent genes, Heme oxygenase-1 (HO-1) is one of the enzymes controlled by Nrf2 that converts the heme to biliverdin, iron and carbon monoxide (CO), important antioxidant and signaling molecules active during stress conditions. [4] Therefore, the Nrf2/HO-1 axis has been shown to be very important for tissue protection and is currently the target of drug discovery approaches.
As uccessful strategy used to disrupt the Keap1-Nrf2 interaction consists in using electrophiles from synthetic or natural sources.B ardoxolone methyl (CDDO-Me, Figure 1 ) is ap otent Natural and synthetic electrophilic compounds have been shown to activate the antioxidant protectiveN rf2 (nuclear factor erythroid 2-relatedf actor 2)/heme oxygenase-1( HO-1) axis in cells and tissues.H ere, we tested the ability of different isoxazoline-based electrophiles to up-regulate Nrf2/HO-1. The potencyo fa ctivation is dependent on the leaving group at the 3-position of the isoxazoline nucleus, and an additional ring on the molecule limits the Nrf2/HO-1 activating properties. Amongt he synthetized compounds, we identified 3-bromo-5-phenyl-4,5-dihydroisoxazole 1 as the derivative with best activating properties in THP-1 human monocytic cells. We have confirmed that the target of our compounds is the Cys151 of the BTB domain of Keap1 by using mass spectrometry analyses and X-ray crystallography.O ur findings demonstrate that these compounds affect the Nrf2/HO-1 axis and highlight ap ositive activity that can be of relevance from a therapeutic perspective in inflammation and infection. activatoro fN rf2 and like the fumarates is thought to act via reactionw ith Cys151 of the Keap-1 protein. [5, 6] In addition to these compounds, other electrophilicm odulators of the Keap1-Nrf2p athway are known including curcumin, 4-hydroxy-2-nonenal, and ebselen ( Figure 1 ). In this context, one of the most studied compounds is sulforaphane, an aturallyo ccurring isothiocyanate isolated from cruciferous vegetables. Numerous electrophiles (e.g.,a crylamidesa nd other a,b-unsaturated groups, boronic acids, and a-halogen-substituted ketones) have been widely employed to design enzymatic covalent inhibitors. Some functionalg roups such as epoxides, aziridines, halomethyl-and acyloxymethyl-ketones are often regarded as too reactive for potentiald rug applications.N onetheless, examples of selective and relatively safe inhibitors bearing those functionalities exist (e.g.,F osfomycin). [11] [12] [13] The 3-halo-4,5-dihydroisoxazole warhead can be consideredarare electrophile in therapeutics since it reacts solely with cysteine residues activated by surrounding amino acid residues present in the catalytic site of an umber of enzymes.S uch ap eculiarity has already been used to design efficacious inhibitors of different enzymatic targets,r anging from parasitic [14] [15] [16] [17] and bacterial enzymes [18, 19] to human targets [20] involved in the modulation of neuronal metabolic pathways or in tumor cell metabolism. [21] In this context, we tested different isoxazoline-based electrophiles ( Figure 2 ) to examinet heir effect on the Nrf2/HO1a xis.
Here the influenceo fd ifferent leaving groups in position 3, i.e.,b romine, chlorine and nitro (compounds 1-3,F igure 2) and of the substituents in position 4a nd 5o ft he isoxazoline ring have been investigated (compounds 4-5,F igure 2). The more interesting derivativesi nt erms of cytotoxic activity,i .e., compounds 1 and 5,a nd other three para-phenyl substituted analogues,i .e.,c ompounds 6-8,h ave been submitted to a mass spectrometry analysis to get the proof of concepto ft he covalenta ddition to Keap1-BTB domain (Broad complex, Tramtrack, and Bric-à-Brac domain). Subsequently,i no rder to determine the covalenta ddition of the ligandst oC ys151 of Keap1-BTB domain, the structure of the complex between Keap1-BTB and 5 was solved by X-ray crystallography. Cysteine-151, in fact, represents one of the major sensors in KEAP1 and its modification is sufficient for robust activation of NRF2. [22] 2. Results and Discussion
Chemistry
The synthesiso fd erivatives 1, 2 and 4-8 was based on the 1,3-dipolar cycloaddition of bromonitrileo xide,g enerated in situ by dehydrohalogenation of the stable precursor dibromoformaldoxime (DBF) [23] to the suitable dipolarophile, affording in all cases the 5-substituted3 -bromo-isoxazoline derivative in very high yield. Derivatives 1, 2, 4 and 7 were previouslyd escribed by us, [24] [25] [26] compound 3 was obtained following al iterature procedure [27] whereas derivatives 5, 6 and 8 were obtained according to Scheme 1.
EffectsonN rf2 Activation and HO-1 Expression
Electrophilic compounds can exert cytotoxic activity and we first examined the viability of human monocytic THP-1 cells exposed to increasingc oncentrationso ft he different compounds. As shown in Figure 3 , compounds 1, 2, 4 and 5 did not causee vident cytotoxicity up to 100 mm.O nly compound 3 promoted cell toxicity (34 %) at the highest concentration of 100 mm;s uch ap rofile could be due to the presence of the nitro group which can be reduced to at oxic hydroxylamine derivative.I ti sn oted that there are many compounds that will induce Nrf2-HO-1 at concentrations lower than those used in the presentstudy [3, 4] but there are also examples of already approvedd rugs, such as dimethylfumarate (DMF), that can be used in the higherm icromolar range (50-100) to affect Nrf2 due to their low cytotoxicity profile. [5] On the contrary,C DDO is very powerful at nanomolar range but it is also very toxic at low micromolar concentrations. Thus, the ability of compounds to induce the Nrf2 system needs to be balanced with their intrinsic cytotoxicity.W hen tested in Western blot experiments, we observed that compounds 1, 3 and 5 increased Nrf2 and HO-1 protein expression at different extents with compound 1 being the most efficient inducer of both proteins (Figure 4a pression (data not shown). The fact that compound 2 activated Nrf2 but did not induce HO-1 expression is not understood at present.T he activation of Nrf2 by derivatives 1, 2, 3 and 5 is strictly related to the nature of the leaving group appended at the 3p osition of the isoxazoline nucleus. As previouslyo bserved on different targets, [16, 17, 25] the 3-bromo-isoxazoline warhead is more active than the 3-chloro counterparts. Finally,t he additional ring presenti nd erivative 4 seems to limit the Nrf2/ HO-1 activating properties.
Mass Spectrometry Analysis
To confirm that the target of our compounds is the BTB domain of Keap1, we purified recombinantp rotein and investigated by mass spectrometry its covalentm odification in the absence or presence of 1, 5, 6, 7 or 8.T he BTB domain comprises three of the 27 cysteines of Keap1,i ncludingC ys151 as the criticals tress sensor. [22] The mass for the protein incubated with DMSO was determined to be 15,190.9 Da in good agreement (within < 30 ppm) to its calculatedm asso f 15, 190 .4645 Da ( Figure 5A ). Incubation of Keap1 BTB with our compounds resulted in the emergence of ap eak with ah igher mass confirming covalent modification of the protein by addition of as ingle compound molecule. For all compounds but 1, the most abundant species corresponds to the derivatized protein with the expected mass ( Figure 5B ). For all compounds, however,a na dditional peak is observed with am ass that fits to ad egradation product in which the phenyl substituent in position5of the isoxazoline ring was eliminated ( Figure 5C ). Variablea mounts of the unmodified protein, intact protein adduct and protein modified with degradation product are observedw ith the different compounds ( Figure 5B ). 
Crystallographic Studies
Kelch-like ECH-associated protein 1( Keap1) controlsN rf2 activation by binding Nrf2 in the cytoplasm and inducing its degradationb yt he proteasome.K eap 1c ontains an umber of cysteins that react with oxidants and electrophiles, thus inducing modification in the Keap1 protein that prevents the binding to and degradation of Nrf2. As ac onsequence, Nrf2 accumulates and enters the nucleus to up-regulate its target genes. [28] The Cys151 residue in the Keap1 protein has been shown to be essentialfor Nrf2 activation by several electrophiles. [29] To confirm Cys151 modification and to identify further interactions and mechanistic consequences, we solved the structure of the Keap1-BTB domain bound to 5 by X-ray crystallography ( Table 1) .
The structure comprises residues 48 to 180, which adopt a conformation very similar to the previously reported Keap1-BTB structures (root mean square deviations on the positiono f 121 to 131 Ca range from 0.38 to 0.53 ). [6, 30] C The presence of continuouse lectron density extending from the Sg atom of Cys 151 shows the presence of covalently bound ligand ( Figure 6 ). Residual difference density extending from Cys151 furthers uggestst hat the cysteine side-chain points in at least two different directions, which could either,i ndicate that the compound induces ac hange in orientation or that the ligand inducese xtreme flexibility and is present in multiple conformations rather than adopting aunique one.
The electron density,h owever,d oes not cover the ligand completely and the aryl substituent in position 5o ft he isoxazoline moiety is only partially defined, the signal fading away from the chiral centre onward. This can be explained by ac ertain flexibility of this part and/or by the presence of multiple conformations. This is consistent both with the absence of interaction with the protein and with the coexistence of two enantiomers of 5.T his limited andr ather unspecific interactions between Keap1-BTB and ac ovalenti nhibitor of Cys151 is, however,n ot uncommon since it was observed in most other published complex structures. [6, 30] The major conformation of 5 that is observed here is consistent with previousK eap1 Cys151 Figure 5 . The isoxazoline covalently modifies asingle cysteine in the BTB domaino fK eap1. A) Deconvoluted intact protein mass spectrum of the native protein (top) and after treatment with 5 (bottom). The masses determined by MS are in good agreement with the theoretical mass for the native protein (15 190 .46 Da) and with that of the protein after covalent modificationo facysteine residue of the protein by compounds. B) Population distribution between native unmodified protein, protein modifiedby the intact compound, and modified protein aftere limination of the aryl substituenta tposition-5 of the isoxazoline moiety.C )The theoreticaland calculated massesare given for the example of the reaction of BTB with 5 and for the degradation product commontoall compounds( Figure5B). (Figure 7 ) and, since the isoxazoline substituent is flexible and not significantly involved in binding, is representative of complexes between Keap1-BTB and our other isooxazoline compounds, including the most potent inhibitor 1 (Sup. Figure 1 ).
Conclusions
Our work demonstrates that certain isoxazoline-based electrophiles, and especially bromo-based derivatives such as compound 1,a re good activators of the Nrf2/HO-1 protective system.I ta ppears that the potency of activation is dependent on leaving group appended at the 3position of the isoxazoline nucleusa nd that an additional ring on the molecule, such as in the case of compound 4,l imits the Nrf2/HO-1a ctivating properties. The ability of compound 5 to covalently bind the Keap1-BTB domain at Cys151 indicates the most likely cysteine target that is critical for allowing the modulation of Nrf2 expression in cells. However,w ec annote xclude that other cysteine residues of Keap1a re modified by our compound and contribute to functional effects.I ti si nterestingt on ote that isoxazolined erivatives have been already shown to inactivate glyceraldehydes-3-phosphate dehydrogenase from Plasmodium falciparum. [25, 26] ·Therefore, our findings that these compounds also affect Nrf2/HO-1 highlight an additional positive activity for these derivatives that can be of relevance from at herapeutic perspective in inflammationand infection.
Experimental Section Materials and Methods
All reagents were purchased from Sigma. 1 
HNMR and
13 CNMR spectra were recorded with aV arian Mercury 300 (300 MHz) spectrometer.C hemical shifts (d)a re expressed in ppm, and coupling constants (J)a re expressed in Hz. TLC analyses were performed on commercial silica gel 60 F 254 aluminium sheets;s pots were further evidenced by spraying with ad ilute alkaline potassium permanganate solution or ninhydrin. Flash chromatography separations were performed on Büchi Pump Manager C-615 and C-601 instruments. Melting points were determined on amodel B540 Büchi apparatus and are uncorrected. Microanalyses (C, H, N) of new compounds were within AE 0.4 %oftheoretical values.
GeneralProcedure for the Cycloaddition Reaction
Solid NaHCO 3 (417 mg, 4.96 mmol) and DBF (402 mg, 1.98 mmol) were added to as olution of the appropriate alkene (0.99 mmol) in CH 2 Cl 2 (4.2 mL). The reaction mixture was stirred at room temperature for 48 ha nd the progress of the reaction was monitored by TLC. Water was added and the organic layer was separated, dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure. Purification of the crude material was performed by column chromatography.
N-(4-(3-Bromo-4,5-dihydroisoxazol-5-yl)phenyl)acetamide (5) a) 4-Vinylaniline (200 mL, 1.71 mmol) was dissolved in AcOH (0.5 mL) and NaOAc (34 mg, 0.51 mmol) and Ac 2 O( 157 mL, 1.71 mmol) were added. The reaction was stirred at room temperature for 30 min. Water (5 mL) was added and the solution was extracted with EtOAc (3 3mL). The organic phase was dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure. Purification of the crude material by column chromatography (cyclohexane/EtOAc 7:3) afforded the protected aniline (160 mg, 58 %y ield). b) Compound 5 was synthesized following the general procedure for the cycloaddition reaction reported above using the acetamide prepared in the previous step. The structure of the BTB/5 complex (white/purple) (PDB ID 6FFM) was superposed to the BTB/CDDO complex structure (light green,P DB ID 4CXT) based on 101 C a positions (rmsd 0.221 ). [6] ChemistryOpen 2018, 7,858 -864 www.chemistryopen.org 
Cell culture and Determination of Cell Viability
The human monocytic cell line THP-1 was cultured under standard conditions in RPMI medium (Gibco) supplemented with 10 %f etal bovine serum, 1% sodium pyruvate (Gibco) and 1% penicillin/ streptomycin (Gibco). One million cells/well were used for viability assay studies. THP-1 cells were incubated for 24 hw ith increasing concentrations (1-100 mm)o ft he compounds 1, 2, 3, 4 and 5 and solvent control (0.1 %D MSO). At the end of the incubation the cell supernatant was collected and lactate dehydrogenase (LDH) activity was measured as an index of cell toxicity according to the manufacturer's instructions (Roche). Only damaged cells release this enzyme in the supernatant and the level of LDH activity correlates with the extent of cellular damage. Triton 2% was used as ap ositive control. Results were expressed as the percentage of cell viability.
Western Blot Analysis for Determination of Nrf2 and HO-1 Protein Expression
Based on the toxicity results, the ability of 1, 2, 4 and 5 to induce Nrf2/HO-1 was assessed at concentrations up to 100 or 200 mm. Compound 3,w hich exhibited significant toxicity at 100 mm,w as tested only up to 50 mm.T HP-1 cells were incubated with the compounds for 6hafter which induction of Nrf2 and HO-1 proteins by Western blot was assessed using specific antibodies. Briefly,c ells were washed in cold PBS before lysis in lysis buffer (20 mm Tris pH 7.4, 137 mm NaCl, 2mm EDTAp H7.4, 1% Triton, 25 mm b-glycerophophate, 1mm Na3VO4, 2mm sodium pyrophosphate, 10 % glycerol, 1mm PMSF,1%m ammalian protease inhibitor). The homogenates were centrifugated at 15,000 rpm for 20 min at 4 8C. Equal amounts of denaturated protein were loaded onto 10 % SDS-PAGE gel and transferred on PVDF membrane (Amersham Biosciences, Les Ulis, France). Membranes were then incubated with antibodies directed against Nrf2 (H-300, Santa Cruz biotechnology, Santa Cruz, USA, 1:1000 dilution in Tris buffer saline Tween 0.2 %, overnight incubation at 4 8C) or HO-1 (Abcam, UK, 1:1000 dilution in 3% bovine serum albumin solution prepared with Tris buffer saline-Tween 0.2 %, 2h incubation at room temperature). Secondary antibodies were anti-rabbit-HRP (7074S, Cell Signaling, 1:2500 dilution in 3% bovine serum albumin solution prepared with Tris buffer saline-Tween 0.2 %) for Nrf2 detection and anti-mouse-HRP (7076S, Cell Signaling, 1:5000 dilution in 3% bovine serum albumin solution prepared with Tris buffer saline-Tween 0.2 %) for HO-1, incubated for 1h at room temperature. The wash buffer was Tris buffer saline-Tween 0.2 %. Immunoreactive bands were detected by chemiluminescence (ECL solution, Amersham Biosciences, Les Ulis, France). b-actin (Santa Cruz biotechnology,S anta Cruz, USA) was used as al oading control. Images were captured using a G:Box F3 imagery station (Syngene, Cambridge, UK).
Recombinant Expression, Purificationand Crystal Structure Determination of the BTB Domain of Keap1
The gene encoding residues 48-180 of human Keap1 (Uniprot Q14 145) were subcloned in am odified pET19 vector to incorporate aT EV cleavable N-terminal hexahistidine tag. As previously reported, as ingle point mutation was also introduced at position 172 (S172A), which enhanced protein stability and crystallizability. [6] The protein was expressed in E. coli BL21 (DE3) and purified to homogeneity as previously described. [6] Prior to crystallization, the BTB domain at 10 mg mL À1 concentration was incubated for 1hon ice in the presence of 3mm 5 (10 %f inal DMSO concentration).
Crystallization was carried out by hanging drop vapour diffusion by mixing equal amounts of protein solution with ac rystallization solution composed of 25-28 %P EG 4000, 0.1 m Tris-HCl pH 8.0 and 0.2 m lithium sulfate. For cryoprotection, the crystals were briefly soaked in as olution composed of the original crystallization mother liquor supplemented with 25 %g lycerol. Diffraction data have been collected on BL14.1 operated by the Helmholtz-Zentrum Berlin (HZB) at the BESSY II electron storage ring (BerlinAdlershof, Germany) [31] and processed using the XDS package. [32] The structure was solved by molecular replacement using Phaser [33] and the previously published structure of the BTB domain of Keap1 as am odel (PDB code 4CXI). Refinement of the structure was performed using phenix.refine [34] until convergence of the R factors. The statistics of the diffraction data as well as of the final model are presented in Ta ble 1. The coordinates of the model as well as the structure factors were deposited to the PDB under accession code 6FFM.
Mass Spectrometry Measurement of the Intact ProteinMasses
To analyze covalent modification(s) of the BTB domain, 10 mm BTB 48-180 (S172A) were incubated with 3mm 1, 5, 6, 7 or 8 (or 3% DMSO final concentration for control) for 1hon ice in 20 mm TrisHCl pH 8.0 and 150 mm NaCl. Intact protein masses were determined through HPLC-coupled electrospray ionization (ESI)-MS on an AB sciex TripleTOF 5600 + mass spectrometer.I ntact proteins were first concentrated and washed on aP iccolo Proto 200 C4 5-mm2.5 0.5-mm trap column (Higgins Analytical) and subsequently switched in line with, and separated on, aJ upiter C4 5-mm3 00-150 1-mm analytical column (Phenomenex) mounted onto aS himadzu Prominence UFLC (Shimadzu) at a7 0mLmin À1 flow rate with the following buffers:A À5% ACN, 5% DMSO, and 0.1 %F A; BÀ90 %A CN, 5% DMSO, and 0.1 %F A. Proteins were then eluted over with ag radient of 3min of 1% Bt o55 %Bfollowed by 1min of 55 %Bto 90 %B .M ass analysis was performed by ESI-TOF-MS on an AB Sciex TripleTOF 5600 + mass spectrometer (Sciex) with a DuoSpray Ion Source with the following settings:f loating voltage of 5,500 V, temperature of 350 8C, declustering potential of 120 with four separate TOF experiments, each, respectively with 4, 12, 20, and 40 time bins summed. Data analysis was performed as follows:s pectra were integrated over ar etention time period, and the summed TOF experiment with the greatest resolution selected. The raw data were then converted and deconvoluted using the MaxEnt Ia lgorithm (Waters) at aresolution of 0.1 Da.
